Students around the globe are concerned about their education loan repayment due to the COVID-19 crisis. We demand a 6 months interest-free extension of education loan grace period.
Please sign this petition and share it with your friends and family who can also be a voice in this initiative #StudentLoanExtension

Labex Lermit

LabEx LERMIT, Rue Jean-Baptiste Clément, Châtenay-Malabry, France

established Established :


The Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT) is one of these 100 projects funded, and one of the 24 selected projects in Life Sciences. LERMIT has received a €19 Mn budget for the period 2011-2020. LERMIT is an interdisciplinary laboratory composed of high-profile biologists, chemists and physico-chemists joining their forces to collectively explore new therapeutic avenues. Our common goal is to combat three major classes of diseases presenting a continuous threat to the society: cancer, cardiovascular diseases, and infectious and immune diseases. To achieve this goal, our joined effort will be directed towards : 1. A better understanding of the molecular mechanisms causing these diseases ; 2. The discovery of new therapeutic targets ; 3. The design and development of new medications to treat - or block the progression of - these diseases ; 4. The development of new strategies for improved targeting and delivery of the medications at the disease site 5. An improved efficacy of current therapeutics. Graduate students and young employees from biotech companies and pharmaceutical industries will be exposed within LERMIT to cutting-edge research developments in drug discovery and therapeutic innovation through unique interdisciplinary training courses. Besides maintaining the highest standards of academic research, LERMIT will generate intellectual property (IP) and value its IP by providing sufficient support for technological maturation and development to generate profit. Effort towards any given new therapeutic strategy will be supported within LERMIT until the preclinical or phase I/II clinical stage. Spin-off biotech companies from LERMIT partners or big-pharma companies will take over at this stage.



No discussions right now. Be the first one to start.

Hey, ask a question or start a discussion here

Choose your question type:

Q/A Profile evaluation Poll Interview experience

Do you work for this organisation?

Start managing your school's profile and gain access to marketing tools and analytics reports.

Request Access
Join the largest Study Abroad community      Log in      Sign up